vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and SYNAPTICS Inc (SYNA). Click either name above to swap in a different company.
SYNAPTICS Inc is the larger business by last-quarter revenue ($302.5M vs $168.4M, roughly 1.8× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 13.2%). Over the past eight quarters, SYNAPTICS Inc's revenue compounded faster (12.9% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Synaptics, Inc. is an American neural network technologies and computer-to-human interface devices development company based in San Jose, California. It develops touchpads and fingerprint biometrics technology for computer laptops; touch, display driver, and fingerprint biometrics technology for smartphones; and touch, video and far-field voice, low-power AI processors, and wireless technology for smart home devices, wearables, and automobiles. Synaptics sells its products to original equipme...
ESPR vs SYNA — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $302.5M |
| Net Profit | — | $-14.8M |
| Gross Margin | — | 43.5% |
| Operating Margin | 50.6% | -5.0% |
| Net Margin | — | -4.9% |
| Revenue YoY | 143.7% | 13.2% |
| Net Profit YoY | — | -922.2% |
| EPS (diluted) | $0.32 | $-0.38 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $302.5M | ||
| Q3 25 | $87.3M | $292.5M | ||
| Q2 25 | $82.4M | $282.8M | ||
| Q1 25 | $65.0M | $266.6M | ||
| Q4 24 | $69.1M | $267.2M | ||
| Q3 24 | $51.6M | $257.7M | ||
| Q2 24 | $73.8M | $247.4M | ||
| Q1 24 | $137.7M | $237.3M |
| Q4 25 | — | $-14.8M | ||
| Q3 25 | $-31.3M | $-20.6M | ||
| Q2 25 | $-12.7M | $-4.7M | ||
| Q1 25 | $-40.5M | $-21.8M | ||
| Q4 24 | — | $1.8M | ||
| Q3 24 | $-29.5M | $-23.1M | ||
| Q2 24 | $-61.9M | $208.3M | ||
| Q1 24 | $61.0M | $-18.1M |
| Q4 25 | — | 43.5% | ||
| Q3 25 | — | 42.6% | ||
| Q2 25 | — | 43.0% | ||
| Q1 25 | — | 43.4% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | — | 46.9% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | — | 46.5% |
| Q4 25 | 50.6% | -5.0% | ||
| Q3 25 | -11.4% | -7.9% | ||
| Q2 25 | 8.6% | -8.6% | ||
| Q1 25 | -34.0% | -9.9% | ||
| Q4 24 | -6.4% | -5.7% | ||
| Q3 24 | -31.0% | -11.0% | ||
| Q2 24 | 3.5% | -12.6% | ||
| Q1 24 | 52.5% | -7.3% |
| Q4 25 | — | -4.9% | ||
| Q3 25 | -35.9% | -7.0% | ||
| Q2 25 | -15.4% | -1.7% | ||
| Q1 25 | -62.2% | -8.2% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | -57.2% | -9.0% | ||
| Q2 24 | -83.9% | 84.2% | ||
| Q1 24 | 44.3% | -7.6% |
| Q4 25 | $0.32 | $-0.38 | ||
| Q3 25 | $-0.16 | $-0.53 | ||
| Q2 25 | $-0.06 | $-0.13 | ||
| Q1 25 | $-0.21 | $-0.56 | ||
| Q4 24 | $-0.14 | $0.05 | ||
| Q3 24 | $-0.15 | $-0.58 | ||
| Q2 24 | $-0.33 | $5.28 | ||
| Q1 24 | $0.34 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $437.4M |
| Total DebtLower is stronger | — | $836.0M |
| Stockholders' EquityBook value | $-302.0M | $1.4B |
| Total Assets | $465.9M | $2.6B |
| Debt / EquityLower = less leverage | — | 0.60× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $437.4M | ||
| Q3 25 | $92.4M | $459.9M | ||
| Q2 25 | $86.1M | $452.5M | ||
| Q1 25 | $114.6M | $421.4M | ||
| Q4 24 | $144.8M | $596.1M | ||
| Q3 24 | $144.7M | $853.6M | ||
| Q2 24 | $189.3M | $876.9M | ||
| Q1 24 | $226.6M | $828.6M |
| Q4 25 | — | $836.0M | ||
| Q3 25 | — | $835.4M | ||
| Q2 25 | — | $834.8M | ||
| Q1 25 | — | $834.2M | ||
| Q4 24 | — | $832.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $983.5M | ||
| Q1 24 | — | — |
| Q4 25 | $-302.0M | $1.4B | ||
| Q3 25 | $-451.4M | $1.4B | ||
| Q2 25 | $-433.5M | $1.4B | ||
| Q1 25 | $-426.2M | $1.4B | ||
| Q4 24 | $-388.7M | $1.4B | ||
| Q3 24 | $-370.2M | $1.5B | ||
| Q2 24 | $-344.2M | $1.5B | ||
| Q1 24 | $-294.3M | $1.2B |
| Q4 25 | $465.9M | $2.6B | ||
| Q3 25 | $364.0M | $2.6B | ||
| Q2 25 | $347.1M | $2.6B | ||
| Q1 25 | $324.0M | $2.6B | ||
| Q4 24 | $343.8M | $2.5B | ||
| Q3 24 | $314.1M | $2.8B | ||
| Q2 24 | $352.3M | $2.8B | ||
| Q1 24 | $373.1M | $2.5B |
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.60× | ||
| Q2 25 | — | 0.60× | ||
| Q1 25 | — | 0.60× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $29.8M |
| Free Cash FlowOCF − Capex | — | $18.2M |
| FCF MarginFCF / Revenue | — | 6.0% |
| Capex IntensityCapex / Revenue | 0.0% | 3.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $154.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $29.8M | ||
| Q3 25 | $-4.3M | $30.2M | ||
| Q2 25 | $-31.4M | $57.2M | ||
| Q1 25 | $-22.6M | $73.4M | ||
| Q4 24 | $-35.0M | $22.8M | ||
| Q3 24 | $-35.3M | $-11.4M | ||
| Q2 24 | $-7.2M | $65.0M | ||
| Q1 24 | $53.8M | $-13.7M |
| Q4 25 | — | $18.2M | ||
| Q3 25 | — | $18.0M | ||
| Q2 25 | — | $50.6M | ||
| Q1 25 | — | $68.0M | ||
| Q4 24 | — | $18.1M | ||
| Q3 24 | $-35.5M | $-20.5M | ||
| Q2 24 | $-7.3M | $57.3M | ||
| Q1 24 | $53.8M | $-22.7M |
| Q4 25 | — | 6.0% | ||
| Q3 25 | — | 6.2% | ||
| Q2 25 | — | 17.9% | ||
| Q1 25 | — | 25.5% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | -68.7% | -8.0% | ||
| Q2 24 | -9.9% | 23.2% | ||
| Q1 24 | 39.0% | -9.6% |
| Q4 25 | 0.0% | 3.8% | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | 0.0% | 2.3% | ||
| Q1 25 | 0.0% | 2.0% | ||
| Q4 24 | 0.0% | 1.8% | ||
| Q3 24 | 0.3% | 3.5% | ||
| Q2 24 | 0.1% | 3.1% | ||
| Q1 24 | 0.1% | 3.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 12.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.31× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SYNA
| Enterprise And Automotive Product Applications | $161.1M | 53% |
| Internet Of Things Product Applications | $93.2M | 31% |
| Mobile Product Applications | $48.2M | 16% |
